Jason Blum’s “Obsession” deal nets $17M as Focus pushes a $200M domestic horror run

Jason Blum’s Blumhouse Atomic is making roughly $17 million in box office bonuses from “Obsession,” TheWrap reports, with the bonus plan triggered after the film hit $25 million domestic and then growing in $5 million domestic increments. The movie has since moved well past that early threshold, grossing over $229 million worldwide and, domestically, reaching a milestone that places it on a rare list of horror films: before inflation, it is on its way to joining “The Exorcist,” “Sinners,” and the “It” films as only the fifth horror movie to gross $200 million domestically.

The core of the payout is deal mechanics. Blum was brought onto “Obsession” as an executive producer about a month and a half after Focus Features acquired the film, to help with marketing, and negotiated a bonus structure that pays him $2 million after $25 million domestic, according to an individual with knowledge of the deal. Blumhouse Atomic also receives additional box office bonuses of $500,000 for every $5 million thereafter, and with those bonuses his company has earned in the ballpark of $17 million, more than Barker or producer Haley Nicole Johnson, according to three individuals familiar with the deals.

To understand why this is such a big deal for decision-makers, you have to zoom out to how “Obsession” went from small and buzzy to commercially enormous. “Obsession,” a psychological thriller about a magical wish gone wrong, was independently produced for just $750,000 by Under the Shell, Tea Shop Productions, and Capstone Pictures. It premiered in the midnight section of last year’s Toronto International Film Festival, where it became one of the buzziest titles at the event. Focus Features then acquired it for $15 million, and Focus released it in May.

Once Focus had the distribution rights, momentum became the product. TheWrap reports that “Obsession” rode positive reviews and Gen Z buzz to a rare box office pattern: it made more in its second weekend than its first, and then made more in its third weekend than its second. That kind of run rate matters because it accelerates when the bonus clock starts ticking, and in this case it appears to have helped “Obsession” clear the domestic milestones that feed the incentive structure Blum negotiated.

The payout also creates a second-order question: who gets the upside when an indie becomes a hit. An individual close to the film said Capstone will make $45 million to $50 million on the film, with the financier sharing that amount with the creative team, including filmmaker Curry Barker. The same individual said Focus stands to make $125 million on the film, and Focus Features did not respond to TheWrap’s request for comment. Meanwhile, Blumhouse Atomic declined to comment for this story. The numbers are important because they show how acquisition economics and incentive clauses can dramatically shift upside allocation, sometimes in ways that are invisible until the box office data comes in.

Blum’s route to the bonus is also instructive for anyone thinking about how executive participation gets valued after acquisition. Blum revealed at the Produced by conference in late May that he came aboard “Obsession” through Barker’s next feature, “Anything but Ghosts.” That horror-comedy, produced by Adam Hendricks and Greg Gilreath, led Blum to contact Barker, with Hendricks and Gilreath calling Blum and urging him to watch “Obsession” ahead of its Toronto debut. After a conversation with Barker, Blum committed to finance “Ghosts,” then he accompanied the filmmaker to the TIFF premiere of “Obsession” where the Focus partnership on both films was struck.

In Blum’s telling, Focus asked about helping market “Obsession,” and he helped. He then pitched Focus boarding “Anything but Ghosts” as well. That sequencing matters because it links creative and commercial roles in a way that can justify later incentive structures. Blumhouse Atomic’s involvement level varies from project to project, but since 2009’s microbudget horror hit “Paranormal Activity,” Blum has built a career shepherding smaller budget horror films to box office success, especially within the genre.

All of this is colliding with a separate but related pressure point in the industry: pay transparency when indie films get acquired and scale. Clarity on Blumhouse Atomic’s deal comes after “Obsession” art director Sally Choi went public Thursday with complaints that she made under $7,000 for what she described as strenuous, cross-department work on the now box office hit. While Choi admitted she knew and agreed to the indie production rate beforehand, she explained, “This is the reality of most filmmakers, especially those who work below the line. We become a line in the budget sheet to keep as low as possible.” Her post went viral and ignited debate about the pay structure of indie productions, especially those that find acquisition and see box office success.

In practical terms, the “Obsession” bonus story forces boards and finance leaders to confront the incentive mismatch problem. The film has grossed over $229 million worldwide, yet the debate sparked by Choi’s experience is about how little below-the-line crew see of that upside. When an executive’s compensation is tightly tied to box office milestones, it can look rational on a deal sheet, but it can also magnify scrutiny of everything else in the budget chain.

For executives deciding how to structure marketing support, distribution partnerships, and post-acquisition participation, the lesson is not just that bonuses exist. It is that these deals can turn modest involvement into outsized upside once a title clears domestic thresholds like $25 million and then keeps climbing. For founders, producers, and investors in the next wave of indie-to-acquired horror and thriller, the strategic stake is simple: if a movie breaks out, incentive design will determine whose upside shows up on the back end, and whose gets left behind in the talk that follows the receipts.